Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333135 · ClinicalTrials.gov registry record · NA
Ultramarathons and Impact of Phased Electromagnetic Field Therapy (PEMF)
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03333135: Completed NA study, sponsored by Mayo Clinic.
NCT03333135 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03333135, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This research is being done to better understand the pulmonary consequences of completing an ultra marathon at altitude and a sea level city.
Primary Outcome
Cardiac ultrasound (Philips CX50) will be performed to determine left and right ventricular morphology and function. Ultrasound will be performed in accordance with the recommendations of the American Society of Echocardiography guidelines (ASE). Imaging of the ventricles and the diameter during relaxation (diastole) will be captured and evaluated. Normal value for right ventricle EDA indexed to body surface area ranges between 5-12.6 cm\^2/m\^2 for males and 4.5-11.5 cm\^2/m\^2 for females .
Interventions
- PROCEDURE Pulsed Electromagnetic Field therapy (PEMF)
- PROCEDURE Pulsed Electromagnetic Field Sham therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2016-12-12 |
| Est. Completion | 2021-06-15 |
| Phase | NA |
What the finished NCT03333135 record still lists
NCT03333135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Pulsed Electromagnetic Field therapy (PEMF) is the first listed.
NCT03333135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03333135 about?
NCT03333135 is a clinical study titled "Ultramarathons and Impact of Phased Electromagnetic Field Therapy (PEMF)". This research is being done to better understand the pulmonary consequences of completing an ultra marathon at altitude and a sea level city.
What is the current status of trial NCT03333135?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2016-12-12. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT03333135?
The interventions under investigation include: Pulsed Electromagnetic Field therapy (PEMF) (PROCEDURE), Pulsed Electromagnetic Field Sham therapy (PROCEDURE).
Who is sponsoring clinical trial NCT03333135?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03333135's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI